Geron GERN fell 50.69% to $1.43 at 9:52 am. Geron announced that, on the basis of an unplanned interim analysis, it is discontinuing its randomized Phase 2 study of imetelstat in metastatic HER2-negative breast cancer.
Nordion NDZ shares dipped 39.06% to $6.49. Nordion announced its plans to suspend its quarterly dividend after an arbitration loss.
Zalicus ZLCS shares lost 26.62% to $1.02. Zalicus announced top line results from its Phase 2b clinical trial of Synavive® in rheumatoid arthritis.
Synergy Pharmaceuticals SGYPU dropped 25.52% to $11.15. Synergy Pharmaceuticals' 52-week trading range is $9.80-$15.88.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in